(Q51562134)

7 April 2018

title

Evidence of a state of increased insulin resistance in preeclampsia. (English)

1 reference

7 April 2018

0 references

1 reference

1 reference

Kaaja R

1

1 reference

7 April 2018

Laivuori H

2

1 reference

7 April 2018

Laakso M

3

1 reference

7 April 2018

Tikkanen MJ

4

1 reference

7 April 2018

Ylikorkala O

5

1 reference

7 April 2018

publication date

1 July 1999

1 reference

7 April 2018

published in

Metabolism

1 reference

7 April 2018

volume

48

1 reference

7 April 2018

issue

7

1 reference

7 April 2018

page(s)

892-896

1 reference

7 April 2018

Pre-eclampsia: more than pregnancy-induced hypertension

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Death rates from ischemic heart disease in women with a history of hypertension in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Cardiovascular sequelae of toxaemia of pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Clinical implications of insulin resistance syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Fatty acids, hyperinsulinemia, and insulin resistance: which comes first?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Insulin sensitivity in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Glucose intolerance as a predictor of hypertension in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

An association between hyperinsulinemia and hypertension during the third trimester of pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Hyperinsulinemia in glucose-tolerant women with preeclampsia. A controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Preeclampsia -- a state of sympathetic overactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Hypertension and pre-eclampsia in women with gestational glucose intolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

High incidence of preeclamptic toxemia in patients with polycystic ovarian disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2899%2990225-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0026-0495(99)90225-1

1 reference

7 April 2018

PubMed ID

10421232

1 reference

7 April 2018